Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 2500.00 | 1321.92 | 4266.00 | 3735.75 | 1.1419 | 1.1852 |
| BT-20 | PLX-4720 | 0.31623 | uM | 3 | 2500.00 | 1321.92 | 3894.00 | 3735.75 | 1.0424 | 1.0561 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 3 | 2500.00 | 1321.92 | 4164.00 | 3735.75 | 1.1146 | 1.1502 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 2500.00 | 1321.92 | 4285.00 | 3735.75 | 1.1470 | 1.1917 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 2500.00 | 1321.92 | 3800.00 | 3735.75 | 1.0172 | 1.0229 |
| BT-20 | Etoposide | 0.031623 | uM | 3 | 2500.00 | 1321.92 | 4308.00 | 3735.75 | 1.1532 | 1.1995 |
| BT-20 | PLX-4720 | 1 | uM | 3 | 2500.00 | 1321.92 | 4169.00 | 3735.75 | 1.1160 | 1.1519 |
| BT-20 | PLX-4720 | 0.031623 | uM | 3 | 2500.00 | 1321.92 | 4100.00 | 3735.75 | 1.0975 | 1.1281 |
| BT-20 | 0 | uM | 3 | 2500.00 | 1321.92 | 3864.00 | 3735.75 | 1.0343 | 1.0456 | |
| BT-20 | 0 | uM | 3 | 2500.00 | 1321.92 | 3446.00 | 3735.75 | 0.9224 | 0.8951 | |
| BT-20 | 0 | uM | 3 | 2500.00 | 1321.92 | 2890.00 | 3735.75 | 0.7736 | 0.6852 | |
| BT-20 | 0 | uM | 3 | 2500.00 | 1321.92 | 3562.00 | 3735.75 | 0.9535 | 0.9375 | |
| BT-20 | Etoposide | 0.01 | uM | 3 | 2500.00 | 1321.92 | 3876.00 | 3735.75 | 1.0375 | 1.0498 |
| BT-20 | Etoposide | 0.31623 | uM | 3 | 2500.00 | 1321.92 | 3549.00 | 3735.75 | 0.9500 | 0.9327 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 2500.00 | 1321.92 | 4265.00 | 3735.75 | 1.1417 | 1.1849 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 2500.00 | 1321.92 | 4574.00 | 3735.75 | 1.2244 | 1.2892 |
| BT-20 | Nilotinib | 0.1 | uM | 3 | 2500.00 | 1321.92 | 4572.00 | 3735.75 | 1.2239 | 1.2886 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 2500.00 | 1321.92 | 1267.00 | 3735.75 | 0.3392 | -0.0279 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 2500.00 | 1321.92 | 4577.00 | 3735.75 | 1.2252 | 1.2902 |
| BT-20 | PLX-4720 | 3.1623 | uM | 3 | 2500.00 | 1321.92 | 4317.00 | 3735.75 | 1.1556 | 1.2026 |
| BT-20 | Nilotinib | 10 | uM | 3 | 2500.00 | 1321.92 | 1947.00 | 3735.75 | 0.5212 | 0.2948 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 3 | 2500.00 | 1321.92 | 4609.00 | 3735.75 | 1.2338 | 1.3009 |
| BT-20 | Nilotinib | 1 | uM | 3 | 2500.00 | 1321.92 | 4553.00 | 3735.75 | 1.2188 | 1.2822 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 3 | 2500.00 | 1321.92 | 4238.00 | 3735.75 | 1.1344 | 1.1756 |
| BT-20 | PLX-4720 | 10 | uM | 3 | 2500.00 | 1321.92 | 3887.00 | 3735.75 | 1.0405 | 1.0537 |